000424

Schumock // Pharmacotherapy, 1998, 18(6), 1284-1289.

180. Tissot, E. Medication Errors at the Administration Stage in an

Intensive Care Unit / E. Tissot [et al.] //Intensive Care. Med., 1999, 25(4),

353-359.

181. Selecting Indicators for Patient Safety at the Health Systems

Level

OECD

Countries.

DELSA/ELSA/WD/HTP(2004)18.(техническийдокументздоровья OECD

DELSA/ELSA/WD/HTP (2004)

182. Spontaneous Reporting Systems Outside the US / B.E. Wiholm

[et al.] // Pharmacoepidemiology, Third Edition by B.L.Strom, 2000, p.175-

192.

183. Suh, D.C. Clinical and economic impact of adverse drug

reactions in hospitalized patients / D.C. Suh, B.S. Woodall, S.K. Shin // Ann

Pharmacother, 2000, 34(12), 1373-1379.

184. Systems analysis of adverse drug events / L. Leape [et al.] //

JAMA, 1995, 274, 35-43.

185. Hochohaus,

Evolution

of prarmacokinetics

and

pharmacokinetics / G. Hochohaus, J.S.Barrett //J. Clin. Pharmacol., 2000. - N

9. -p.908-917.

186. The costs of adverse drug events in hospitalized patients / D.W.

Bates [et al.] // JAMA, 1997, 277, 307-311.

187. The Institute for Healthcare Improvement, The Quest for Error-

Proof Medicine, Drug Benefit, 1997, 9(6), 18-29.

188. Van Maaren, P.J.M. Dutch druds in developing countries. Styx

Publication, Nothern Centre for Health Care, University of Gronibgen, 1994.

189. Vere, D.W. Drug adverse reactions as masqueraders / D.W. Vere

// Adverse Drug Reaction Bull. - 1976. - 60: 208-211.

190. Vincen, J. D. Radiometry - fundamentals of infrared detector

operation and testing / J. D. Vincen. - New York: Wiley, 1990. - Ch. 3.

- 197 -

197